Załącznik nr 3 do procedury opracowywania i okresowego przeglądu programów kształcenia
Appendix no. 3 to the procedure of development and periodical review of syllabuses
Syllabus
1. Imprint
Faculty name:
Faculty of Medicine and Dentistry
Education program (field of study, level
and educational profile, form of studies,
e.g., Public Health, 1st level studies,
practical profile, full time):
Dentistry, stationary, the theoretical and practical profile
Academic year:
2015/2016
Module/subject name:
Pharmacology
Subject code (from the Pensum system):
25422
Educational units:
Head of the unit/s:
Chair and Department of Experimental and Clinical
Pharmacology
Centre for Preclinical Research and Technology CePT,
Banacha 1b, 02-927 Warsaw, tel. (+48) 022 1166160
Prof. Dagmara Mirowska-Guzel MD, PhD, SciD
tel. (+48) 022 1166160
Study year (the year during which the
respective subject is taught):
III year
Study semester (the semester during
which the respective subject is taught):
V i VI semester
Module/subject type (basic,
corresponding to the field of study,
optional):
Basic
Teachers (names and surnames and
degrees of all academic teachers of
respective subjects):
ERASMUS YES/NO (Is the subject
available for students under the
ERASMUS programme?):
Ewa Widy-Tyszkiewicz MD, PhD, SciD
Aleksandra Wisłowska-Stanek MD, PhD
Jan Bembenek MD, PhD.
Yes
A person responsible for the syllabus (a
person to which all comments to the
syllabus should be reported)
Ewa Widy-Tyszkiewicz MD, PhD, SciD
Number of ECTS credits:
7 points
Strona 1 z 6
Załącznik nr 3 do procedury opracowywania i okresowego przeglądu programów kształcenia
Appendix no. 3 to the procedure of development and periodical review of syllabuses
2. Educational goals and aims
1.
Acquisition of facts, concepts and principles of rational pharmacotherapy
2. Understanding the basic benefits, dangers and difficulties associated with the therapy
3. Initial requirements
1.
Basic information in the field of microbiology, physiology and pathophysiology.
4. Learning outcomes corresponding to the subject
A list of course learning outcomes
Description of course learning outcomes
The reference to
programme learning
outcomes (number)
Student knows the basics of disinfection, sterilization and
aseptic procedures
C.W5.
W_02
They know and understand the phenomenon of drug
resistance
C.W9.
W_03
Student knows and understands the mechanisms of
action of drugs and the pharmacokinetics and
biotransformation of various groups of drugs
C.W18.
W_04
Student knows the indications and contraindications to
the use of drugs, their dosage, side effects and toxicity
and drug-drug interactions
C.W19.
W_05
Student knows and understands the rules of treatment of
viral, bacterial, fungal and parasitic diseases
C.W20.
W_06
Student knows and understands the principles of
preventing and combating pain and anxiety, and
pharmacology of drugs used in life-threatening conditions
C.W21.
W_07
Student knows the rules of prescription writing of some
forms of medicinal products and prescription writing on
the prescription
C.W22.
Symbol of course learning
outcomes
W_01
Strona 2 z 6
Załącznik nr 3 do procedury opracowywania i okresowego przeglądu programów kształcenia
Appendix no. 3 to the procedure of development and periodical review of syllabuses
U_01
Student interprets the results of microbiological,
serological and susceptibility tests
U_02
Student prescribes drugs dosed according to the
indications
C.U2
C.U8
5. Forms of classes
Form
Number of hours
Number of groups
Lecture
15
1
Seminar
25
1
Practical classes
35
1
6. Subject topics and educational contents
W1-Lecture 1 - Drugs used in pregnancy
W2-Lecture 2 - Drugs used in shock
W3-Lecture 3 - Drugs used in headaches.
W4-Lecture 4 - Drugs used in ischemic heart disease
W5-Lecture 5 - Treatment of Parkinson's disease
W6-Lecture 6 - Treatment of elderly people
W7-Lecture 7 – Antiarrhythmic drugs
W8-Lecture 8 - Treatment of poisonings
S1-Seminar 1- General pharmacology
S2-Seminar 2 – Chemotherapy
S3-Seminar 3 - Non-narcotic analgesic drugs
S4-Seminar 4 - Treatment of anemia.
S5-Seminar 5 - Pharmacology of the gastrointestinal tract
S6-Seminar 6 – Parasympathetic system
S7-Seminar 7 - Drugs used to treat diabetes
S8-Seminar 8 – Glucocorticoids
S9-Seminar 9 - Oral contraceptives
S11-Seminar 11 - Drugs used in heart failure
S12-Seminar 12 - Drugs used in hypertension
S13-Seminar 13 - The respiratory system drugs
S14-Seminar 14 - The central nervous system drugs (1)
S15-Seminar 15 - The central nervous system drugs (2)
S10-Seminar 10 - Drugs used to treat thyroid problems
C1-Practical class 1 – Chemotherapy (1)
Strona 3 z 6
Załącznik nr 3 do procedury opracowywania i okresowego przeglądu programów kształcenia
Appendix no. 3 to the procedure of development and periodical review of syllabuses
C2-Practical class 2 – Chemotherapy (2)
C3-Practical class 3 - Narcotic analgesic drugs
C4-Practical class 4 - Drugs that affect coagulation
C5-Practical class 5 - Disinfectants and antiseptic
C6- Practical class 6 - Pharmacology of the gastrointestinal tract
C7- Practical class 7 - Basics of prescription writing
C8- Practical class 8 - Prescription writing
C9-Practical class 9 - Stimulants of the sympathetic nervous system
C10-Practical class 10 - Drugs that inhibit the sympathetic nervous system
C11-Practical class 11 - Local-anesthetic medication.
C12-Practical class 12 - Myorelaxant drugs
C13-Practical class 13 - Drugs used in general anesthesia
C14-Practical class 14 - Antiepileptic drugs
C15-Practical class 15 – Prescription writing
C16-Practical class 16 –Prescription writing
7. Methods of verification of learning outcomes
Learning
outcome
corresponding to
the subject
(symbol)
W_01, W_02,
W_04, W_05,
W_06, W_07,
U._01 .
Forms of classes
(symbol)
L, S, C
U._02
C
Methods of verification of
a learning outcome
Credit receiving criteria
Oral examination or a
multiple choice test
>50%
Written credit prescription
writing
>90%
8. Evaluation criteria
Form of receiving credit in a subject:
grade
criteria
2.0 (failed)
<50%
3.0 (satisfactory)
51-58%
3.5 (rather good)
59-68%
4.0 (good)
69-74%
4.5 (more than good)
79-80%
5.0 (very good)
>80%
Strona 4 z 6
Załącznik nr 3 do procedury opracowywania i okresowego przeglądu programów kształcenia
Appendix no. 3 to the procedure of development and periodical review of syllabuses
9. Literature
Obligatory literature:
1. Katzung B, Masters S, Trevor A. Basic and Clinical Pharmacology 12/E
(LANGE Basic Science), Appleton-Lange Medical Publications 2012
2. Rang HP, Dale \M, Ritter JM, Flower RJ, Henderson G. Rang & Dale's
Pharmacology: with STUDENT CONSULT Online Access, 7/E, Elsevier, Churchill Livingstone 2012
3. Goodman and Gilman’s the Pharmacological Basis of Therapeutics. McGraw-Hill Professional;
12 edition, 2010
Supplementary literature:
1. Waldman SA, Terzic A. Pharmacology and Therapeutics: Principles to Practice, Saunders 2008.
10. ECTS credits calculation
Form of activity
Number of hours
Number of ECTS credits
Direct hours with an academic teacher:
Lectures
15
2
Seminars
25
3
Practical classes
35
3
Student's independent work (examples of the form of work):
Student's preparation for a seminar
165
Student's preparation for a class
Preparation for obtaining credits
Other (please specify)
Total
240
11. Additional Information
Form of the assessment of the course:
Students are obliged to attend all seminars, classes and lectures.
After V and VI semester students are obliged to complete the prescription writing and the oral
colloquium/MCQ test in the scope of classes, seminars and lectures.
Credits of the test on V and VI semester entitles the student to take the final examination after semester VI.
Seminars ,classes and lectures are held at the Center for Library and Information and in the
Educational Centre
Rules on colloquiums and Q&A tests
1. Students are informed about the date/time and the venue for Q&A tests either for semester
colloquium or final exam at least one month in advance.
2. Students are expected to arrive at the venue at least 15 minutes before test start. Those who are
late more than 15 minutes after the test start are not allowed to enter and are kindly invited for the
retake.
3. To facilitate students identification ID document (preferably student record book) need to be
presented, otherwise student are not allowed to take the test.
4. Students are asked to wait outside the room and can enter only following identification confirmed.
5. Students are allocated the individual place which is pointed by invigilator.
Strona 5 z 6
Załącznik nr 3 do procedury opracowywania i okresowego przeglądu programów kształcenia
Appendix no. 3 to the procedure of development and periodical review of syllabuses
6. The test is based on student individual work - unauthorized materials (including revision
notes) and mobile phones are disallowed. Communication with any person during the exam,
other than the invigilator, is prohibited and can be the cause for student banning.
7. For Q&A tests only one answer is correct.
8. To pass the test students need to provide 50% + 1 (i.e. 51 for 100 questions) correct answers. If
more than 20% of students score less, subsequently the threshold is lowered accordingly to keep
the failures rate below 20%. The final individual score is based on the number of correct answers
provided and other students’ performance (the distribution of test results).
9. The form and the time of retake is individually decided with the teacher.
10. Test results are made available on the Department website (www.farmakologia.wum.edu.pl) as
soon as possible.
Signature of the Head of the Unit
Signature of the person responsible for the syllabus
Strona 6 z 6